These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16776502)
1. Synthesis and evaluation of ketophosph(on)ates as beta-lactamase inhibitors. Perumal SK; Pratt RF J Org Chem; 2006 Jun; 71(13):4778-85. PubMed ID: 16776502 [TBL] [Abstract][Full Text] [Related]
2. Inverse acyl phosph(on)ates: substrates or inhibitors of beta-lactam-recognizing enzymes? Morrison MJ; Li N; Pratt RF Bioorg Chem; 2001 Oct; 29(5):271-81. PubMed ID: 16256697 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of beta-lactamases by monocyclic acyl phosph(on)ates. Kaur K; Adediran SA; Lan MJ; Pratt RF Biochemistry; 2003 Feb; 42(6):1529-36. PubMed ID: 12578365 [TBL] [Abstract][Full Text] [Related]
4. Beta-ketophosphonates as beta-lactamase inhibitors: Intramolecular cooperativity between the hydrophobic subsites of a class D beta-lactamase. Perumal SK; Adediran SA; Pratt RF Bioorg Med Chem; 2008 Jul; 16(14):6987-94. PubMed ID: 18572409 [TBL] [Abstract][Full Text] [Related]
5. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates. Nagarajan R; Pratt RF Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621 [TBL] [Abstract][Full Text] [Related]
6. Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors. Silvaggi NR; Kaur K; Adediran SA; Pratt RF; Kelly JA Biochemistry; 2004 Jun; 43(22):7046-53. PubMed ID: 15170342 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of penam sulfones as inhibitors of beta-lactamases. Phillips OA; Reddy AV; Setti EL; Spevak P; Czajkowski DP; Atwal H; Salama S; Micetich RG; Maiti SN Bioorg Med Chem; 2005 Apr; 13(8):2847-58. PubMed ID: 15781395 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of 3-(carboxymethylidene)- and 3-(carboxymethyl)penicillinates as inhibitors of beta-lactamase. Buynak JD; Ghadachanda VR; Vogeti L; Zhang H; Chen H J Org Chem; 2005 May; 70(11):4510-3. PubMed ID: 15903334 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum beta-lactamase inhibitors: evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods. Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Ado M; Tsuyoshi T; Dos Santos O; Gu Y; Sum FW; Li Z; Francisco G; Lin YI; Petersen PJ; Yang Y; Kumagai T; Weiss WJ; Shlaes DM; Knox JR; Mansour TS J Med Chem; 2006 Jul; 49(15):4623-37. PubMed ID: 16854068 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases. Richter HG; Angehrn P; Hubschwerlen C; Kania M; Page MG; Specklin JL; Winkler FK J Med Chem; 1996 Sep; 39(19):3712-22. PubMed ID: 8809160 [TBL] [Abstract][Full Text] [Related]
11. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity. Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896 [TBL] [Abstract][Full Text] [Related]
12. Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH. Watkins WJ; Chen JM; Cho A; Chong L; Collins N; Fardis M; Huang W; Hung M; Kirschberg T; Lee WA; Liu X; Thomas W; Xu J; Zeynalzadegan A; Zhang J Bioorg Med Chem Lett; 2006 Jul; 16(13):3479-83. PubMed ID: 16621550 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of class D beta-lactamases by diaroyl phosphates. Majumdar S; Adediran SA; Nukaga M; Pratt RF Biochemistry; 2005 Dec; 44(49):16121-9. PubMed ID: 16331972 [TBL] [Abstract][Full Text] [Related]
14. Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-beta-lactamases. Lassaux P; Hamel M; Gulea M; Delbrück H; Mercuri PS; Horsfall L; Dehareng D; Kupper M; Frère JM; Hoffmann K; Galleni M; Bebrone C J Med Chem; 2010 Jul; 53(13):4862-76. PubMed ID: 20527888 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and beta-lactamase reactivity of alpha-substituted phenaceturates. Adediran SA; Cabaret D; Flavell RR; Sammons JA; Wakselman M; Pratt RF Bioorg Med Chem; 2006 Oct; 14(20):7023-33. PubMed ID: 16806948 [TBL] [Abstract][Full Text] [Related]
16. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244. Thomson JM; Distler AM; Bonomo RA Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099 [TBL] [Abstract][Full Text] [Related]
17. Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence. Totir MA; Cha J; Ishiwata A; Wang B; Sheri A; Anderson VE; Buynak J; Mobashery S; Carey PR Biochemistry; 2008 Apr; 47(13):4094-101. PubMed ID: 18324783 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of potential new inhibitors of the bacterial transferase MraY with a β-ketophosphonate structure. Auberger N; Frlan R; Al-Dabbagh B; Bouhss A; Crouvoisier M; Gravier-Pelletier C; Le Merrer Y Org Biomol Chem; 2011 Dec; 9(24):8301-12. PubMed ID: 22042341 [TBL] [Abstract][Full Text] [Related]
19. Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate. Beck J; Vercheval L; Bebrone C; Herteg-Fernea A; Lassaux P; Marchand-Brynaert J Bioorg Med Chem Lett; 2009 Jul; 19(13):3593-7. PubMed ID: 19467869 [TBL] [Abstract][Full Text] [Related]